Seattle-based Know Labs incorporated its Bio-RFID sensor into the first generation of this technology. The proprietary Bio-RFID technology uses spectroscopy to direct electromagnetic energy through a substance or material. Through this, it can capture a unique molecular signature. The Know Labs technology integrates into wearable, mobile or bench-top form factors.
This non-invasive technology demonstrated technical feasibility and stability in blood glucose measurements in a lab environment. Now, the company revealed this technology incorporated in a portable device.
According to Know Labs, no medical-grade, commercially available non-invasive means of measuring blood glucose exist currently. The company hopes to deliver the first FDA-cleared non-invasive blood glucose monitor for those with diabetes and pre-diabetes.
Get the full story at our sister site, Drug Delivery Business News.